Published: Jul, 2018
The Kingdom of Saudi Arabia veterinary therapeutics market is anticipated in a report by Transparency Market Research (TMR) to witness a high level of competition in the near future. The degree of competition could increase as a result of the entry of new companies in the market. In 2016, an over 50.0% of the total market share was secured by leading companies Boehringer, Bayer Animal Health, Merck Animal Health, Elanco Animal Health, and Zoetis, Inc. With new companies entering the market, there could be a range of products available for end users. The whole of Middle East is expected to find an increase in the count of public-private partnerships.
TMR prognosticates the Kingdom of Saudi Arabia veterinary therapeutics market to rise at a 4.7% CAGR during the forecast tenure 2017-2025 to reach to a US$0.5 bn valuation by 2025. In 2016, the market was worth a US$0.3 bn. On the basis of type of product, pharmaceuticals could gather pace to lead the market with its 58.5% share expected by the final forecast year.
Need to Treat and Prevent Bacterial Infections in Animals Draws Strong Demand
Rising awareness about animal healthcare is predicted to emerge as a powerful factor augmenting the demand in the Kingdom of Saudi Arabia veterinary therapeutics market. Nutritional feed, vaccines, and drugs included in veterinary therapeutics are used to maintain the overall health of animals. They are used for treating and preventing different types of bacterial and infectious conditions in animals. Demand for veterinary therapeutics could increase on the back of rising use of livestock and companion animals for domestication and food.
Other factors envisaged to set the tone for valuable growth in the Kingdom of Saudi Arabia veterinary therapeutics market are increase in animal healthcare spending, improving affordability, introduction of groundbreaking products for battling new animal diseases, and growing ownership of companion animals.
Low Returns on Research and Development Investment Delay Growth in Market
Undesirable returns on investment in research and development is foreseen to hamper the growth of the Kingdom of Saudi Arabia veterinary therapeutics market. The returns are observed to be not as fruitful despite heavy investment made in the development of advanced medicines. Moreover, owing to their detrimental side effects, some antibiotics have been banned in the market. This is also expected to cause problems to players operating in the industry.
However, drastic increase in zoonotic diseases improving demand for veterinary therapeutics is foretold to set the Kingdom of Saudi Arabia market for positive growth. Sales of veterinary therapeutic products could surge while riding on the need to ensure the wellbeing of animals and prevent animal diseases. Swelling consumption of dairy and poultry products could be another factor helping with market growth.
The information presented in this review is based on a TMR report, titled “Veterinary Therapeutics Market (Product - Pharmaceuticals (Ectoparasiticides, Endoparasiticides, Antibiotics, Anti-inflammatories, and Endectocides), Vaccines (Bacterial and Viral), Nutritional Feed Additives (Amino Acids, Vitamins, and Minerals), and Disinfectants (Floor Disinfectants and Disinfectants Used in Tissues); Animal Type - Companion Animals (Dogs and Cats) and Livestock Animals (Cattle, Sheep, and Poultry)) - Kingdom of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
The Kingdom of Saudi Arabia veterinary therapeutics market has been segmented as presented below:
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Product
- Nutritional Feed Additives
- Amino Acids
- Floor Disinfectants
- Disinfectants Used in Tissues
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Animal Type
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.